Terms: = Bone cancer AND HNRNPA2B1, ENSG00000122566, SNRPB1, RNPA2, HNRPB1, HNRPA2, HNRNPB1, HNRNPA2, 3181
9 results:
1. Spinal lesions in multiple myeloma: Primary bone tumors with distinct prognostic factors.
Ly R; Terrier LM; Cognacq G; Benboubker L; Destrieux C; Velut S; Zemmoura I; Francois P; Aggad M; Amelot A
Surg Oncol; 2023 Jun; 48():101927. PubMed ID: 36966661
[TBL] [Abstract] [Full Text] [Related]
2. m
Liu R; Zhong Y; Chen R; Chu C; Liu G; Zhou Y; Huang Y; Fang Z; Liu H
Theranostics; 2022; 12(18):7760-7774. PubMed ID: 36451863
[No Abstract] [Full Text] [Related]
3. hnrnpa2b1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.
Jia C; Guo Y; Chen Y; Wang X; Xu Q; Zhang Y; Quan L
J Transl Med; 2022 Nov; 20(1):537. PubMed ID: 36401285
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial.
Blayney DW; Mohanlal R; Adamchuk H; Kirtbaya DV; Chen M; Du L; Ogenstad S; Ginn G; Huang L; Zhang Q
JAMA Netw Open; 2022 Jan; 5(1):e2145446. PubMed ID: 35084480
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.
Wang J; Du X; Wang X; Xiao H; Jing N; Xue W; Dong B; Gao WQ; Fang YX
Cancer Lett; 2022 Feb; 526():76-90. PubMed ID: 34801597
[TBL] [Abstract] [Full Text] [Related]
6. [DNA sequencing of H3F3A mutations in H3.3 immunohistochemistry-negative giant cell tumors of bone].
Gong LH; Zhang W; Sun XQ; Zhang M; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):190-193. PubMed ID: 33677880
[No Abstract] [Full Text] [Related]
7. Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma.
Kundu AK; Iyer SV; Chandra S; Adhikari AS; Iwakuma T; Mandal TK
PLoS One; 2017; 12(6):e0179168. PubMed ID: 28636657
[TBL] [Abstract] [Full Text] [Related]
8. Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study).
Adamo V; Franchina T; Adamo B; Ferraro G; Rossello R; Maugeri SaccĂ M; Scibilia C; Valerio MR; Russo A
Ann Oncol; 2007 Jun; 18 Suppl 6():vi11-5. PubMed ID: 17591801
[TBL] [Abstract] [Full Text] [Related]
9. Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma.
Nanus DM; Garino A; Milowsky MI; Larkin M; Dutcher JP
Cancer; 2004 Oct; 101(7):1545-51. PubMed ID: 15378501
[TBL] [Abstract] [Full Text] [Related]